Sanofi ADR (NASDAQ:SNY) shares traded -0.08% lower at $50.56 on Wall Street last session.
SNY stock price is now -7.93% away from the 50-day moving average and -4.41% away from the 200-day moving average. The market capitalization of the company currently stands at $123.77B.
With the price target of $65, Exane BNP Paribas recently initiated with Outperform rating for Sanofi ADR (NASDAQ: SNY). On March 21, 2025, Goldman recently initiated its ‘Neutral’ rating on the stock quoting a target price of $65, while ‘Deutsche Bank’ rates the stock as ‘Hold’
A total of 0.00% of the company’s stock is owned by insiders.
During the past 12 months, Sanofi ADR has had a low of $45.22 and a high of $60.12. As of last week, the company has a debt-to-equity ratio of 0.23, a current ratio of 1.08, and a quick ratio of 0.73. According to the stock market information, the enterprise value for the company is $74088595456, which is based on a 21.12 price-to-earnings ratio, a 1.68 price-to-earnings-growth ratio, and a beta of 0.57. The fifty day moving average price for SNY is $54.9176 and a two-hundred day moving average price translates $52.8903 for the stock.
The latest earnings results from Sanofi ADR (NASDAQ: SNY) was released for 2024-12-31. The net profit margin was 13.54% and return on equity was 7.34% for SNY. The company reported revenue of $8.03 billion for the quarter, compared to $13.14 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -38.89 percent.
